Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
49,463,144
-
Shares change
-
-4,402,307
-
Total reported value, excl. options
-
$80,622,599
-
Value change
-
-$5,927,964
-
Put/Call ratio
-
17%
-
Number of buys
-
35
-
Number of sells
-
36
-
Price
-
$1.63
Institutional Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q1 2023
As of 31 Mar 2023 Xeris Biopharma Holdings, Inc. - COM (XERS) had 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 49,463,144 shares of stock of the company.
Largest 10 holders included Stonepine Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, CAXTON CORP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Invesco Ltd., NORTHERN TRUST CORP, Redmile Group, LLC, and Tudor Investment Corp Et Al.
This table shows 89 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.